ArticleHeliyon2023
Revaluating the dietary methionine requirements in an improved strain of nile tilapia (
Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 1 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
It has been shown with terrestrial animals that the genetic improvement increases the nutrient requirements of the animal, which becomes more efficient in using these nutrients to achieve their higher growth potential. This study was conducted to estimate the dietary methionine requirements of different generations of the Genetically Improved Farmed Tilapia (GIFT) strain of Nile tilapia at the juvenile stage (17.51 g-19.55 g initial body weight). To achieve this objective, a completely randomized 2 × 6 factorial design was applied, with the genetic background of fish (generation) as the first independent variable with two levels, the 16th and 17th generations, and the methionine content of the diet as the second independent variable, with 6 graded levels, 0.52, 0.62, 0.84, 0.94, 1.04 and 1.27% of methionine in the diets, respectively. At the end of the 42-day experiment, the interaction effect of the generation × diet was not significant (P > 0.05) for any of the response parameters studied. The genetic improvement led to 15% more growth in the 17th generation than the 16th generation of the GIFT strain of Nile tilapia, which was accompanied with better feed conversion ratio, protein productive value, and energy productive value in the former generation (P < 0.05). Whatever the generation considered, the optimum dietary methionine requirement for the growth of the improved GIFT strain of Nile tilapia was estimated in this study, using the broken-line model, between 0.75% and 0.80% of the diet (with a cysteine level of 0.50% of the diet), which is higher than 0.49% of the diet previously estimated for conventional Nile tilapia at the juvenile stage. Therefore, the genetic improvement applied to the GIFT strain of Nile tilapia likely led to a higher methionine and total sulfur amino acid requirement than the conventional strains. The results of this study support the need to update the existing nutrient requirement databases of fish, in order to ensure that diets are formulated to effectively satisfy the requirements of not only conventional, but also improved strains of fish, for the full expression of their accrued growth potential of the latter strains.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.